GlassScriptPhysician profile
Wayneinder S Anand
NPI 1184743544
$6,281.56
in general payments reported to CMS, 2019-2025
39 companies · $1,645 in 2025
The $1,645 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,881 · 2020: $993 · 2021: $120 · 2022: $64.93 · 2023: $259 · 2024: $1,318 · 2025: $1,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,943 · Travel and Lodging: $162 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,943.49 |
| Travel and Lodging | $162.14 |
| Education | $117.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,295.86 | 2019-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $881.48 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $386.89 | 2019-2024 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Advanced Respiratory, INC | $353.46 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $342.33 | 2019-2025 | Zerbaxa, Gardasil 9, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $333.58 | 2020-2025 | |
| Grifols USA, LLC | $294.31 | 2019-2025 | Prolastin-C Liquid |
| Philips North America LLC | $282.49 | 2019-2025 | Incourage Airway Clearance Therapy |
| Amgen INC. | $263.15 | 2024-2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $187.36 | 2019-2024 | |
| Cook Incorporated | $162.14 | 2024 | Melker |
| United Therapeutics Corporation | $139.06 | 2024-2025 | Tyvaso, Tyvaso |
| Genentech USA, INC. | $125.18 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $112.32 | 2019-2020 | |
| Verona Pharma, INC. | $97.35 | 2025 | Ohtuvayre |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $97.16 | 2019 | |
| Pfizer INC. | $92.93 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $87.99 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $79.55 | 2019 | |
| Insmed, INC. | $72.70 | 2021-2025 | Arikayce |
| Getinge USA Sales, LLC | $64.74 | 2020 | |
| Sunovion Pharmaceuticals INC. | $58.30 | 2019 | |
| Baxter Healthcare | $45.68 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Ani Pharmaceuticals, INC. | $44.33 | 2024 | Purified Cortrophin Gel |
| Allergan, INC. | $41.25 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $36.11 | 2020 | |
| Lilly USA, LLC | $32.15 | 2024 | Mounjaro |
| Shionogi INC | $30.83 | 2024 | Fetroja |
| Teleflex LLC | $30.45 | 2025 | Arrow |
| Gilead Sciences, INC. | $29.59 | 2019 | |
| Mylan Specialty L.P. | $27.09 | 2024 | Yupelri |
| Jazz Pharmaceuticals INC. | $24.76 | 2024 | |
| Viatris Specialty LLC | $24.16 | 2025 | Yupelri |
| Exact Sciences Corporation | $24.15 | 2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $22.33 | 2019 | |
| Avanir Pharmaceuticals, INC. | $16.40 | 2019 | |
| Circassia INC. | $15.07 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.88 | 2019 | |
| Paratek Pharmaceuticals, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayneinder Anand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.